Off-label use of orphan medicinal products: a Belgian qualitative study

Off-label use of (orphan) medicinal products for (rare) diseases is quite common but not underpinned by clinical studies to confirm efficacy and safety. No risk-analyses by regulatory agencies are carried out....
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Source Type: research